Patient Questions This blog was prompted by a colleague who sent me the above picture
Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver
same drug, different label) If you have moderate obesity (BMI 30 to 35): Semaglutide (Ozempic for diabetes, Wegovy for obesity) or liraglutide (Victoza for diabetes, Saxenda for obesity) If you want the simplest regimen: Once-weekly semaglutide or tirzepatide Goal: Minimize injection frequency Once weekly: Semaglutide, tirzepatide, dulaglutide, efpeglenatide, retatrutide Every two weeks (pipeline): Ecnoglutide (pending approval) Oral (no injections): Semaglutide (Rybelsus) or orforglipron (Orfoglip) Goal: Minimize gastrointestinal side effects Lower nausea profile: Tirzepatide (dual agonist
Nestl Health Science, a globally managed business unit within Nestl, has been working to transform health management
Glucomannan: the appetite synergist Glucomannan is a soluble fiber derived from the konjac root
Compounded drugs are not FDA-approved, which means the agency does not review their safety, effectiveness or quality before they are marketed